News

Castor announces the appointment of Brad Hightower, a leading clinical trials executive, to its advisory board.

Real-world evidence has the potential to transform evidence based medicine, by generating a body of evidence that provides a much more accurate view on what cure is best for each individual patient.

By reducing the effort, cost, and time needed, Castor Virtual Visits enhance convenience and flexibility – upgrading the patient experience while also amplifying retention rates and data reliability.

As CPTO for Castor, Andrew Sadler, brings more than 25 years of experience building, growing and leading engineering teams from startups to enterprise tech companies such as Google and Oracle.

Castor announces the launch of its CRO Partnership program designed to increase adoption of decentralized clinical trials and support CROS

Castor announced transformative growth with anticipated topline acceleration driven by the company’s momentous US market expansion

CB Insights named Castor to its third annual Digital Health 150, which showcases the 150 most promising private digital health companies in the world.

Industry veteran Milind Kamkolkar joins Castor’s Board of Directors to advance mission of democratizing clinical research by maximizing the impact of clinical data.

Castor’s DCT platform helping medical device trials achieve compliance with patient-focused technology  Driving innovation for medical device clinical…